These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1601 related items for PubMed ID: 18387426

  • 21. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
    Guglielmetti S, Mora D, Gschwender M, Popp K.
    Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Review article: probiotics and prebiotics in irritable bowel syndrome.
    Spiller R.
    Aliment Pharmacol Ther; 2008 Aug 15; 28(4):385-96. PubMed ID: 18532993
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.
    Leventer SM, Raudibaugh K, Frissora CL, Kassem N, Keogh JC, Phillips J, Mangel AW.
    Aliment Pharmacol Ther; 2008 Jan 15; 27(2):197-206. PubMed ID: 17973974
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Octatropine methyl bromide and diazepam combination (Valpinax) in patients with irritable bowel syndrome: a multicentre, randomized, placebo-controlled trial.
    Pace F, Maurano A, Ciacci C, Savarino V, Attili A, Iaquinto G, Magni E, Porro GB.
    Eur Rev Med Pharmacol Sci; 2010 Mar 15; 14(3):155-62. PubMed ID: 20391952
    [Abstract] [Full Text] [Related]

  • 30. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome.
    Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR.
    Aliment Pharmacol Ther; 2009 Mar 01; 29(5):508-18. PubMed ID: 19053980
    [Abstract] [Full Text] [Related]

  • 31. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome.
    Nobaek S, Johansson ML, Molin G, Ahrné S, Jeppsson B.
    Am J Gastroenterol; 2000 May 01; 95(5):1231-8. PubMed ID: 10811333
    [Abstract] [Full Text] [Related]

  • 32. Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome.
    Drossman DA, Danilewitz M, Naesdal J, Hwang C, Adler J, Silberg DG.
    Am J Gastroenterol; 2008 Oct 01; 103(10):2562-9. PubMed ID: 18775020
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effectiveness of probiotics in the treatment of irritable bowel syndrome.
    Wilhelm SM, Brubaker CM, Varcak EA, Kale-Pradhan PB.
    Pharmacotherapy; 2008 Apr 01; 28(4):496-505. PubMed ID: 18363533
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome.
    Kajander K, Krogius-Kurikka L, Rinttilä T, Karjalainen H, Palva A, Korpela R.
    Aliment Pharmacol Ther; 2007 Aug 01; 26(3):463-73. PubMed ID: 17635381
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 81.